SDMHF
Price
$218.00
Change
-$0.50 (-0.23%)
Updated
Feb 20 closing price
Capitalization
28.9B
WAT
Price
$374.82
Change
-$5.99 (-1.57%)
Updated
Feb 21 closing price
Capitalization
20.38B
72 days until earnings call
Ad is loading...

SDMHF vs WAT

Header iconSDMHF vs WAT Comparison
Open Charts SDMHF vs WATBanner chart's image
Sartorius Stedim Biotech
Price$218.00
Change-$0.50 (-0.23%)
Volume$2
Capitalization28.9B
Waters
Price$374.82
Change-$5.99 (-1.57%)
Volume$272.14K
Capitalization20.38B
SDMHF vs WAT Comparison Chart
Loading...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SDMHF vs. WAT commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SDMHF is a Hold and WAT is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (SDMHF: $218.00 vs. WAT: $374.82)
Brand notoriety: SDMHF and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SDMHF: 0% vs. WAT: 60%
Market capitalization -- SDMHF: $28.9B vs. WAT: $20.38B
SDMHF [@Medical Specialties] is valued at $28.9B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SDMHF’s FA Score shows that 1 FA rating(s) are green whileWAT’s FA Score has 1 green FA rating(s).

  • SDMHF’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 1 green, 4 red.
According to our system of comparison, WAT is a better buy in the long-term than SDMHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

WAT’s TA Score shows that 5 TA indicator(s) are bullish.

  • WAT’s TA Score: 5 bullish, 5 bearish.

Price Growth

SDMHF (@Medical Specialties) experienced а -0.23% price change this week, while WAT (@Medical Specialties) price change was +1.38% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

WAT is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SDMHF($28.9B) has a higher market cap than WAT($20.4B). SDMHF has higher P/E ratio than WAT: SDMHF (35.84) vs WAT (31.78). SDMHF YTD gains are higher at: 11.795 vs. WAT (1.035). SDMHF has higher annual earnings (EBITDA): 1.16B vs. WAT (1B). WAT has more cash in the bank: 396M vs. SDMHF (113M). SDMHF has less debt than WAT: SDMHF (1.31B) vs WAT (2.44B). SDMHF has higher revenues than WAT: SDMHF (3.36B) vs WAT (2.96B).
SDMHFWATSDMHF / WAT
Capitalization28.9B20.4B142%
EBITDA1.16B1B116%
Gain YTD11.7951.0351,139%
P/E Ratio35.8431.78113%
Revenue3.36B2.96B114%
Total Cash113M396M29%
Total Debt1.31B2.44B54%
FUNDAMENTALS RATINGS
SDMHF vs WAT: Fundamental Ratings
SDMHF
WAT
OUTLOOK RATING
1..100
5052
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
8743
SMR RATING
1..100
8221
PRICE GROWTH RATING
1..100
4555
P/E GROWTH RATING
1..100
1535
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WAT's Valuation (80) in the Medical Specialties industry is in the same range as SDMHF (83) in the null industry. This means that WAT’s stock grew similarly to SDMHF’s over the last 12 months.

WAT's Profit vs Risk Rating (43) in the Medical Specialties industry is somewhat better than the same rating for SDMHF (87) in the null industry. This means that WAT’s stock grew somewhat faster than SDMHF’s over the last 12 months.

WAT's SMR Rating (21) in the Medical Specialties industry is somewhat better than the same rating for SDMHF (82) in the null industry. This means that WAT’s stock grew somewhat faster than SDMHF’s over the last 12 months.

SDMHF's Price Growth Rating (45) in the null industry is in the same range as WAT (55) in the Medical Specialties industry. This means that SDMHF’s stock grew similarly to WAT’s over the last 12 months.

SDMHF's P/E Growth Rating (15) in the null industry is in the same range as WAT (35) in the Medical Specialties industry. This means that SDMHF’s stock grew similarly to WAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
WAT
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
60%
Advances
ODDS (%)
Bullish Trend 3 days ago
68%
Declines
ODDS (%)
Bearish Trend 9 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
View a ticker or compare two or three
Ad is loading...
WAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFWIX13.75-0.09
-0.65%
DFA World ex US Core Equity Instl
RLEFX35.30-0.35
-0.98%
American Funds American Balanced R5E
SPMHX9.13-0.10
-1.08%
Invesco SteelPath MLP Alpha R5
SHXIX14.54-0.24
-1.62%
American Beacon Shapiro Equity Opps R5
MSGCX11.40-0.28
-2.40%
Meridian Small Cap Growth C

SDMHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SDMHF has been loosely correlated with SOAGY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDMHF jumps, then SOAGY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDMHF
1D Price
Change %
SDMHF100%
N/A
SOAGY - SDMHF
44%
Loosely correlated
-0.49%
SRTOY - SDMHF
35%
Loosely correlated
N/A
JNDOF - SDMHF
30%
Poorly correlated
N/A
WAT - SDMHF
25%
Poorly correlated
-1.57%
SNN - SDMHF
24%
Poorly correlated
+1.59%
More